Show simple item record

dc.contributor.authorKeyhanian, Kiandokht
dc.contributor.authorUmeton, Raffaella Pizzolato
dc.contributor.authorMohit, Babak
dc.contributor.authorDavoudi, Vahid
dc.contributor.authorHajighasemi, Fatemeh
dc.contributor.authorGhasemi, Mehdi
dc.date2022-08-11T08:08:09.000
dc.date.accessioned2022-08-23T15:44:38Z
dc.date.available2022-08-23T15:44:38Z
dc.date.issued2020-11-07
dc.date.submitted2020-11-25
dc.identifier.citation<p>Keyhanian K, Umeton RP, Mohit B, Davoudi V, Hajighasemi F, Ghasemi M. SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation. J Neuroimmunol. 2020 Nov 7;350:577436. doi: 10.1016/j.jneuroim.2020.577436. Epub ahead of print. PMID: 33212316; PMCID: PMC7647896. <a href="https://doi.org/10.1016/j.jneuroim.2020.577436">Link to article on publisher's site</a></p>
dc.identifier.issn0165-5728 (Linking)
dc.identifier.doi10.1016/j.jneuroim.2020.577436
dc.identifier.pmid33212316
dc.identifier.urihttp://hdl.handle.net/20.500.14038/27357
dc.description.abstractSince the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a growing body of evidence indicates that besides common COVID-19 symptoms, patients may develop various neurological manifestations affecting both the central and peripheral nervous systems as well as skeletal muscles. These manifestations can occur prior, during and even after the onset of COVID-19 general symptoms. In this Review, we discuss the possible neuroimmunological mechanisms underlying the nervous system and skeletal muscle involvement, and viral triggered neuroimmunological conditions associated with SARS-CoV-2, as well as therapeutic approaches that have been considered for these specific complications worldwide.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=33212316&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647896/
dc.subjectCoronavirus disease 2019 (COVID-19)
dc.subjectEncephalitis
dc.subjectGuillain-Barré syndromes
dc.subjectMyelitis
dc.subjectNeuroimmunity
dc.subjectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
dc.subjectImmunology of Infectious Disease
dc.subjectImmunopathology
dc.subjectInfectious Disease
dc.subjectNervous System
dc.subjectNervous System Diseases
dc.subjectNeuroscience and Neurobiology
dc.subjectVirus Diseases
dc.titleSARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation
dc.typeArticle
dc.source.journaltitleJournal of neuroimmunology
dc.source.volume350
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/covid19/150
dc.identifier.contextkey20304135
html.description.abstract<p>Since the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a growing body of evidence indicates that besides common COVID-19 symptoms, patients may develop various neurological manifestations affecting both the central and peripheral nervous systems as well as skeletal muscles. These manifestations can occur prior, during and even after the onset of COVID-19 general symptoms. In this Review, we discuss the possible neuroimmunological mechanisms underlying the nervous system and skeletal muscle involvement, and viral triggered neuroimmunological conditions associated with SARS-CoV-2, as well as therapeutic approaches that have been considered for these specific complications worldwide.</p>
dc.identifier.submissionpathcovid19/150
dc.contributor.departmentDepartment of Neurology
dc.source.pages577436


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record